텔레 파머시 시장 예측 : 서비스별, 제공 형태별, 디바이스별, 최종사용자별, 지역별 분석(-2034년)

According to Stratistics MRC, the Global Telepharmacy Market is accounted for $15.3 billion in 2026 and is expected to reach $59.0 billion by 2034 growing at a CAGR of 18.4% during the forecast period. Telepharmacy encompasses remote pharmaceutical services delivered via telecommunications and digital platforms. It enables pharmacists to provide medication consultations, therapy management and dispensing remotely. Telepharmacy enhances accessibility to pharmacy services, especially in underserved regions, facilitates medication adherence, and offers virtual consultations, aiding in patient care and medication support through remote interactions and technological solutions.

According to the National Institute of Health (NIH) survey on patients' perspectives and preferences in adopting telepharmacy versus in-person visits to the pharmacy during the COVID-19 pandemic, about 77% of respondents preferred appointments via telepharmacy.

Market Dynamics:

Driver:

Growing demand for remote healthcare solutions

The increasing demand for remote healthcare solutions drives the telepharmacy market. Factors such as geographic barriers, limited access to pharmacies and the need for convenient healthcare options, especially in rural or underserved areas, fuel this demand. Telepharmacy addresses these challenges by offering remote pharmaceutical services, including medication consultations, therapy management, and prescription refills. The growing preference for virtual interactions, coupled with the desire for accessible and timely healthcare, positions telepharmacy as a pivotal solution, propelling its adoption and market growth.

Restraint:

Challenges in obtaining licenses across different jurisdictions

Different regulations and licensing requirements in different regions or states demand complex compliance procedures. Telepharmacy services operating across multiple jurisdictions must navigate varied legal frameworks, which often involve rigorous and time-consuming processes for licensure. The need for adherence to distinct regulations complicates operations, increases administrative burdens, and hampers swift market expansion. This challenge of navigating diverse licensing requirements across jurisdictions impedes the seamless delivery of telepharmacy services, limiting geographic reach and scalability.

Opportunity:

Growing awareness regarding the telepharmacy

The increasing awareness surrounding telepharmacy presents a significant opportunity in the market. As remote healthcare solutions grow among patients and healthcare providers, there's heightened recognition of the benefits telepharmacy offers, including improved accessibility to pharmaceutical services, enhanced medication management and expanded healthcare reach, especially in underserved areas. This awareness fosters greater acceptance and adoption of telepharmacy solutions, encouraging both patients and healthcare organizations to embrace these remote services, thereby driving the market's growth and facilitating a more widespread implementation of telepharmacy initiatives.

Threat:

Privacy and data security risks

Handling sensitive patient information remotely increases vulnerability to cyber threats, data breaches and unauthorized access. Protecting patient confidentiality and complying with stringent privacy regulations have become paramount. Mishandling or unauthorized disclosure of health data erodes patient trust and could lead to legal repercussions, which further hinders market expansion.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption of telepharmacy solutions. The crisis highlighted the need for remote healthcare access, prompting increased reliance on telemedicine and telepharmacy services. Lockdowns, social distancing measures and healthcare facility limitations pushed patients and providers to embrace remote consultations, prescription refills and medication management through telepharmacy platforms. This surge in demand showcased telepharmacy's potential in ensuring continuity of care, shaping a long-term shift towards remote pharmaceutical services.

The patient counselling segment is expected to be the largest during the forecast period

The patient counselling segment is expected to dominate the telepharmacy market due to its pivotal role in medication management and patient-centric care. Telepharmacy facilitates personalized counseling, empowering patients with comprehensive medication guidance, dosage instructions, and adverse effects management. As healthcare increasingly focuses on patient engagement and adherence, telepharmacy's ability to offer remote counseling services, especially for chronic conditions or complex therapies, becomes crucial. This demand for tailored counseling propels the patient counselling segment, emphasizing its significance in ensuring effective pharmaceutical care through telepharmacy services.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to experience substantial growth in the telepharmacy market due to evolving healthcare dynamics. Hospitals increasingly adopt telepharmacy to optimize patient care, streamline medication management, and extend services remotely. The integration of telepharmacy solutions within hospital systems enhances medication adherence and facilitates virtual consultations, especially for discharged patients or those with chronic conditions. Additionally, telepharmacy augments healthcare access, reducing readmission rates and ensuring continuous medication support, positioning the hospitals segment for significant expansion.

Region with largest share:

North America is expected to register the largest market share in the telepharmacy market, owing to its advanced healthcare infrastructure, tech-driven innovation, and mature telehealth landscape. The region boasts robust regulatory frameworks supporting telepharmacy adoption. Furthermore, increased healthcare spending, a growing aging population, and the emphasis on improving healthcare access drive the demand for remote pharmaceutical services. With established telehealth practices and widespread digital connectivity, North America is primed to lead in telepharmacy, leveraging its technological prowess and healthcare advancements to cater to evolving patient needs.

Region with highest CAGR:

Asia Pacific is set to witness substantial growth in the telepharmacy market due to the region's expanding healthcare infrastructure, increasing adoption of digital technology and rising demand for accessible healthcare services. Telepharmacy addresses geographical barriers, especially in remote areas, by offering convenient access to pharmaceutical expertise. Moreover, the region's tech-savvy population and the escalating need for efficient healthcare delivery systems further propel the adoption of telepharmacy solutions, positioning Asia Pacific for lucrative growth in remote pharmaceutical services.

Key players in the market

Some of the key players in telepharmacy market include Capsule Technologies, CPS Solutions, LLC, Digital Pharmacist Inc., McKesson Ventures, Medication Review, Inc., Medtel Communications, Omnicell, Inc., PharmaPoint, PioneerRx, Pipeline Healthcare, TelePharm (Cardinal Health), Transaction Data Systems, Inc. and ZipDrug.

Key Developments:

In May 2023, OneroRx is pleased to announce that Community Pharmacy of Dunlap is open to serve residents of Dunlap, Iowa, and its surrounding communities. Community Pharmacy has worked closely with Dunlap Community Development Corporation (DCDC) to bring pharmacy services back to the area.

In July 2022, RxLive, a provider of population health pharmacy solutions, today announced a $5 million Series A funding round. The digital health startup's round was led by SpringTide, a healthtech-focused venture capital firm, with participation by Cardinal Health(TM), a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions in health care. RxLive has raised a total of $8 million to date.

Services Covered:

• Drug Therapy Monitoring
• Patient Counselling
• Refill Authorization for Prescription Drugs
• Remote Dispensing
• Other Services

Delivery Modes Covered:

• On-premises
• Cloud-based
• Web-based

Devices Covered:

• Computers
• Smartphones
• Tablets and Kiosk

End Users Covered:

• Primary Care Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Telepharmacy Market, By Service

• 5.1 Introduction
• 5.2 Drug Therapy Monitoring
• 5.3 Patient Counselling
• 5.4 Refill Authorization for Prescription Drugs
• 5.5 Remote Dispensing
• 5.6 Other Services

6 Global Telepharmacy Market, By Delivery Mode

• 6.1 Introduction
• 6.2 On-premises
• 6.3 Cloud-based
• 6.4 Web-based

7 Global Telepharmacy Market, By Device

• 7.1 Introduction
• 7.2 Computers
• 7.3 Smartphones
• 7.4 Tablets and Kiosk

8 Global Telepharmacy Market, By End User

• 8.1 Introduction
• 8.2 Primary Care Centers
• 8.3 Hospitals
• 8.4 Other End Users

9 Global Telepharmacy Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Capsule Technologies
• 11.2 CPS Solutions, LLC
• 11.3 Digital Pharmacist Inc.
• 11.4 McKesson Ventures
• 11.5 Medication Review, Inc.
• 11.6 Medtel Communications
• 11.7 Omnicell, Inc.
• 11.8 PharmaPoint
• 11.9 PioneerRx
• 11.10 Pipeline Healthcare
• 11.11 TelePharm (Cardinal Health)
• 11.12 Transaction Data Systems, Inc.
• 11.13 ZipDrug